Clinical Trial Update: Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating pegylated interferon alfa plus epoetin alfa for chronic hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)
• Pegylated interferon (pegylated interferon alfa)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED